Does RIBOFLAVIN Cause Mobility decreased? 118 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 118 reports of Mobility decreased have been filed in association with RIBOFLAVIN. This represents 13.9% of all adverse event reports for RIBOFLAVIN.
118
Reports of Mobility decreased with RIBOFLAVIN
13.9%
of all RIBOFLAVIN reports
118
Deaths
117
Hospitalizations
How Dangerous Is Mobility decreased From RIBOFLAVIN?
Of the 118 reports, 118 (100.0%) resulted in death, 117 (99.2%) required hospitalization, and 117 (99.2%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOFLAVIN. However, 118 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOFLAVIN Cause?
Off label use (410)
Drug ineffective (372)
Nausea (271)
Drug hypersensitivity (270)
Product use in unapproved indication (265)
Pain (264)
Infusion related reaction (225)
Swelling (223)
Sleep disorder (214)
Pericarditis (210)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which RIBOFLAVIN Alternatives Have Lower Mobility decreased Risk?
RIBOFLAVIN vs RIBOFLAVIN 5'-PHOSPHATE
RIBOFLAVIN vs RIBOFLAVIN 5^-PHOSPHATE
RIBOFLAVIN vs RIFABUTIN
RIBOFLAVIN vs RIFAMPICIN
RIBOFLAVIN vs RIFAMPIN